References
- Saleem Z, Hassali MA, Godman B, et al. Point prevalence surveys of antimicrobial use: a systematic review and the implications. Expert Rev Anti Infect Ther. 2020;18(9): 897–910. doi:10.1080/14787210.2020.1767593. .
- Hofer U. The cost of antimicrobial resistance. Nature Rev Microbiol. 2019;17(1):3.
- Singh SK, Sengupta S, Antony R, et al. Variations in antibiotic use across India: multi-centre study through global point prevalence survey. J Hosp Infect. 2019;103(3):280–283. DOI:10.1016/j.jhin.2019.05.014.
- Al Matar M, Enani M, Binsaleh G, et al. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016. J Infect Public Health. 2019;12(1):77–82. DOI:10.1016/j.jiph.2018.09.003.
- Boucher HW, Bakken JS, Murray BE. The United Nations and the urgent need for coordinated global action in the fight against antimicrobial resistance. Ann Intern Med. 2016;165(11):812–813.
- World Health Organisation. Antimicrobial resistance. 2018. [cited 2020 September 23]. Available at URL: http://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
- Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6): e619–e29. doi:10.1016/S2214-109X(18)30186-4. .
- WHO. Global action plan on antimicrobial resistance. 2015. [cited 2020 September 24]. Available at URL: https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1
- Plachouras D, Karki T, Hansen S, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveillance. 2018;23(46):1–14.
- IM ABDULLAH. Multiple drugs resistance among urinary tract infection patients in Duhok city–Kurdistan Region–Iraq. Duhok Med J. 2019;13(1):22–31. DOI:10.31386/dmj.2019.13.1.3
- Moghnieh RA, Kanafani ZA, Tabaja HZ, et al. Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. Lancet Infect Dis. 2018;18(12):e379–e94.
- Al-Charrakh AH, Al-Awadi SJ, Mohammed AS. Detection of Metallo-β-lactamase producing pseudomonas aeruginosa isolated from public and private hospitals in Baghdad, Iraq. Acta Med Iran. 2016;54(2):107–113.
- Hussein NH. Emergence of NDM-1 among carbapenem-resistant Klebsiella pneumoniae in Iraqi hospitals. Acta Microbiol Immunol Hung. 2018;65(2):211–227.
- Nassr OA, Alridha AMA, Naser RA, et al. Antibiotic prescribing in the acute care in Iraq. Hernia. 2018;13:16.9. .
- Obaid AA-R. Prescribing pattern of antibiotics in AL-Elwia Pediatric Teaching Hospital, Baghdad, 2016. Al-Kindy Coll Med J. 2017;13(2):117–126.
- Sabeeh DQ, Abdulrahman NM, Abass ZA-R. Magnitude of prescribed antibiotics in pediatric emergency department in Basra hospital for maternity and children. Global J Public Health Med. 2020;2(1):125–131.
- The Lancet Global Health Supplementary appendix to Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. [cited 2020 September 24]. Available at URL: https://www.global-pps.com/wp-content/uploads/2018/05/1-2-LANGH-2015_Global-PPS_results-on-adults_Appendix_Versporten_April2018.pdf
- Al Hilfi TK, Lafta R, Burnham G. Health services in Iraq. Lancet. 2013;381(9870):939–948.
- EMRO WHO. Iraq develops national action plan to address antimicrobial resistance. 2017. [cited 2020 September 23]. Available from: http://www.emro.who.int/irq/iraq-news/moh-in-collaboration-with-who-develops-national-action-plan-tackling-antimicrobial-resistance-in-iraq.html
- Antony CR, Moore M, Hilborne LH, et al. Strengthening health care in the Kurdistan Region of Iraq. 2017. (cited 2020 September 24). Available at URL: https://www.rand.org/pubs/research_briefs/RB9990.html
- Aboulenein A, Levinson R Iraq’s healthcare has fallen far. 2020. [cited 2020 September 24]. Available at URL: https://www.reuters.com/article/us-iraq-health-drugs-idUSKBN20P1RP
- WHO Regional office for the Eastern mediterranean comprehensive assessment of Iraq’s health information system 2019. 2019. [cited 2020 September 24]. Available at URL: https://applications.emro.who.int/docs/9789290223160-eng.pdf
- DK AFRIYIE, IA SEFAH, SNEDDON J. et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist.. 2020; 1–9.
- WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification system: guidelines for ATC classification and DDD assignment. 2020. [cited 2020 September 24]. Available from: https://www.whocc.no/atc_ddd_index/
- Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO Essential medicines list for optimal use—be AWaRe. Lancet Infect Dis. 2018;18(1): 18–20. doi:10.1016/S1473-3099(17)30724-7. .
- Saleem Z, Hassali MA, Versporten A, et al. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019;17(4):285–293. DOI:10.1080/14787210.2019.1581063.
- Guclu E, Ogutlu A, Karabay O, et al. Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study. J Chemother. 2017;29(1):19–24. DOI:10.1080/1120009X.2016.1156893.
- Nathwani D, Varghese D, Stephens J, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):35. DOI:10.1186/s13756-019-0471-0.
- Momanyi L, Opanga S, Nyamu D, et al. Antibiotic prescribing patterns at a leading referral hospital in Kenya: a point prevalence survey. J Res Pharm Pract. 2019;8(3):149–154.
- Anand Paramadhas BD, Tiroyakgosi C, Mpinda-Joseph P, et al. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications. Expert Rev Anti Infect Ther. 2019;17(7):535–546. DOI:10.1080/14787210.2019.1629288.
- Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680.
- Charani E, Tarrant C, Moorthy K, et al. Understanding antibiotic decision making in surgery—a qualitative analysis. Clin Microbiol Infect. 2017;23(10):752–760.
- Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102.
- Jumaa KM, Hussien SAR, Jaffer AM, et al. Latif RAA: antibiotic prescription style in surgery department in Baquba Teaching Hospital. Diyala J Pure Sci. 2010;6(3):152–166.
- Mohammed S, Ahmed M, Karem K. Incidence of multi-drug resistant escherichia coli isolates from blood and Urine in Kerbala, Iraq. J kerbala univ. 2014;12(4):222–227.
- WHO. Iraq - national medicines list/formulary/standard treatment guidelines. compact essential drugs list 2010. [cited 2020 September 24]. Available at URL: https://www.who.int/selection_medicines/country_lists/IRQ_NML_10.pdf?ua=1
- Pollack LA, Plachouras D, Sinkowitz-Cochran R, et al. A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel. Infect Control Hosp Epidemiol. 2016;37(10):1201–1211.
- Chigome AK, Matlala M, Godman B, et al. Availability and use of therapeutic interchange policies in managing antimicrobial shortages among South African public sector hospitals; findings and implications. Antibiotics. 2019;9(1):4. DOI:10.3390/antibiotics9010004.
- Liaskou M, Duggan C, Joynes R, et al. Pharmacy’s role in antimicrobial resistance and stewardship. Clinical Pharmacy. 2018. [cited 2020 September 24]. Available at URL; https://www.pharmaceutical-journal.com/research/review-article/pharmacys-role-in-antimicrobial-resistance-and-stewardship/20204885.article?firstPass=false
- Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97–S100.
- World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A who practical toolkit. 2019. [cited 2020 September 24]. Available at URL: https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf